Agenda

Return

C. 48

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	January 10, 2023

Contra

Costa

County

Subject:

Amendment to Purchase Order with Hologic, Inc. (PO #18098)

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 01/10/2023

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Ken Carlson, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:

Stephanie Trammell, 925-370-5775

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: January 10, 2023
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment to purchase order #18098 with Hologic, Inc., to increase the payment limit by $1,500,000 to a new payment limit of $2,500,000 00 to procure testing reagents, kits and related laboratory testing supplies for the period from January 1, 2020 to January 16, 2024.

FISCAL IMPACT:

Approval of this action will result in additional expenditures of up to $1,500,000 over the four-year period and will be funded by 100% Hospital Enterprise Fund I revenues.

BACKGROUND:

Hologic, Inc. has provided testing reagents to the Contra Costa County Public Health Laboratory since 2015. Hologic is the manufacturer and provider of testing reagents for both of the Public Health Laboratory's Hologic Panther instruments. Panther testing reagents and kits are used to conduct testing for Chlamydia, Gonorrhea, Trichomonas vaginalis, Mycoplasma genitalium, Herpes Simplex Virus (HSV) 1 & 2, HIV viral load, HCV viral load, HBV viral load testing, and SARS-CoV-2 screening at the Contra Costa County Public Health Laboratory. Routine high-volume sexually transmitted infection (STI) testing is performed on Hologic instrumentation on a daily basis.

During the COVID-19 pandemic, diagnostic testing demand has fluctuated for all laboratory assays. As the pandemic response recedes and the community returns to regular pre-pandemic activities, testing demand has increased and additional funds are needed. Additionally, as new tests have been offered on the current platforms and providers become more familiar with the available test menu, testing demand from the Hologic platform will also increase.

On January 7, 2020, the Board of Supervisors approved agenda item C.36 to execute a purchase order with Hologic, Inc. in the amount of $1,000,000 to purchase testing reagents and related laboratory supplies for the period of January 1, 2020 through December 31, 2022.

On July 12, 2022, the Board of Supervisors approved agenda item C.115 to execute an amendment to purchase order (#18098) with Hologic, Inc., to extend the term through January 16, 2024 with no change to the payment limit of $1,000,000 to procure laboratory testing supplies.

Approval of this amendment will allow this vendor to provide additional testing reagents, kits and related laboratory supplies to meet the laboratory's demand through January 16, 2024.

CONSEQUENCE OF NEGATIVE ACTION:

If the purchase order amendment is not approved, the Contra Costa Public Health Laboratory will be unable to purchase the additional testing reagents, kits and related laboratory supplies to incorporate additional STI screening and viral load testing when necessary, as per CDC recommendations.